Підписатись
Talia Velasco-Hernandez
Talia Velasco-Hernandez
Assistant professor Serra Hunter. Universidad de Barcelona
Підтверджена електронна адреса в ub.edu
Назва
Посилання
Посилання
Рік
Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells
D Li, ND Marchenko, R Schulz, V Fischer, T Velasco-Hernandez, F Talos, ...
Molecular Cancer Research 9 (5), 577-588, 2011
3172011
Metabolic and innate immune cues merge into a specific inflammatory response via the UPR
DA Mogilenko, JT Haas, L L’homme, S Fleury, S Quemener, ...
Cell 177 (5), 1201-1216. e19, 2019
1262019
HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia
T Velasco-Hernandez, A Hyrenius-Wittsten, M Rehn, D Bryder, ...
Blood, The Journal of the American Society of Hematology 124 (24), 3597-3607, 2014
1102014
Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia
D Sánchez-Martínez, ML Baroni, F Gutierrez-Agüera, H Roca-Ho, ...
Blood, The Journal of the American Society of Hematology 133 (21), 2291-2304, 2019
972019
Potential pitfalls of the Mx1-Cre system: implications for experimental modeling of normal and malignant hematopoiesis
T Velasco-Hernandez, P Säwén, D Bryder, J Cammenga
Stem cell reports 7 (1), 11-18, 2016
742016
41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo
ML Baroni, DS Martinez, FG Aguera, HR Ho, M Castella, SR Zanetti, ...
Journal for immunotherapy of cancer 8 (1), 2020
422020
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells
M Eriksson, P Peña-Martínez, R Ramakrishnan, M Chapellier, C Högberg, ...
Blood advances 1 (23), 2046-2057, 2017
422017
CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity
C Bueno, T Velasco-Hernandez, F Gutiérrez-Agüera, SR Zanetti, ...
Leukemia 33 (8), 2090-2125, 2019
382019
Hyaluronic acid–GPRC5C signalling promotes dormancy in haematopoietic stem cells
YW Zhang, J Mess, N Aizarani, P Mishra, C Johnson, MC Romero-Mulero, ...
Nature cell biology 24 (7), 1038-1048, 2022
352022
Deregulation of genes related to iron and mitochondrial metabolism in refractory anemia with ring sideroblasts
M del Rey, R Benito, C Fontanillo, FJ Campos-Laborie, K Janusz, ...
PLoS One 10 (5), e0126555, 2015
322015
A novel and efficient tandem CD19-and CD22-directed CAR for B cell ALL
SR Zanetti, T Velasco-Hernandez, F Gutierrez-Agüera, VM Díaz, ...
Molecular Therapy 30 (2), 550-563, 2022
272022
p53 restoration kills primitive leukemia cells in vivo and increases survival of leukemic mice
T Velasco-Hernández, C Vicente-Dueñas, I Sánchez-García, ...
Cell Cycle 12 (1), 122-132, 2013
232013
Loss of HIF-1α accelerates murine FLT-3ITD-induced myeloproliferative neoplasia
T Velasco-Hernandez, D Tornero, J Cammenga
Leukemia 29 (12), 2366-2374, 2015
222015
Hif-1Α deletion may lead to adverse treatment effect in a mouse model of Mll-Af9-driven aml
T Velasco-Hernandez, S Soneji, I Hidalgo, E Erlandsson, J Cammenga, ...
Stem cell reports 12 (1), 112-121, 2019
212019
Distinct roles for PARP-1 and PARP-2 in c-Myc–driven B-cell lymphoma in mice
MA Galindo-Campos, N Lutfi, S Bonnin, C Martínez, ...
Blood, The Journal of the American Society of Hematology 139 (2), 228-239, 2022
182022
The “Never-Ending” mouse models for MLL-rearranged acute leukemia are still teaching Us
K Ottersbach, A Sanjuan-Pla, R Torres-Ruíz, C Bueno, ...
HemaSphere 2 (4), e57, 2018
122018
Engraftment characterization of risk-stratified AML in NSGS mice
R Díaz de la Guardia, T Velasco-Hernandez, F Gutiérrez-Agüera, ...
Blood advances 5 (23), 4842-4854, 2021
102021
Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope
T Velasco-Hernandez, SR Zanetti, H Roca-Ho, F Gutierrez-Aguera, ...
Journal for immunotherapy of cancer 8 (2), 2020
102020
Induction of the 5S RNP–Mdm2–p53 ribosomal stress pathway delays the initiation but fails to eradicate established murine acute myeloid leukemia
P Jaako, A Ugale, M Wahlestedt, T Velasco-Hernandez, J Cammenga, ...
Leukemia 31 (1), 213-221, 2017
72017
Opportunities for CAR-T Cell Immunotherapy in HIV Cure
G Campos-Gonzalez, J Martinez-Picado, T Velasco-Hernandez, ...
Viruses 15 (3), 789, 2023
52023
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20